Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Tag: ADP101
Alladapt’s 15-Allergen OIT Candidate Ready to Begin Phase 1/2 Study
Dave Bloom
-
2022/01/04
ADP101 is intended to treat patients with an allergy to one or more of peanut, almond, hazelnut, cashew, pistachio, pecan, walnut, milk, egg, cod, salmon, shrimp, wheat, soy, and sesame.
Alladapt Enrolling Participants for Clinical Study of OIT Therapy to Treat...
Dave Bloom
-
2021/08/19
The study is still seeking participants 4-55 years of age.
Broad Spectrum OIT Candidate for Multiple Food Allergies Begins Phase 1/2...
Dave Bloom
-
2021/04/22
The Harmony Study plans to enroll patients across 20 sites in the United States.
Alladapt Immunotherapeutics Secures $60 Million in Series C Financing for Development...
News Wire ~ 3rd Party Press Release
-
2020/02/21
Company is developing therapy to target a number of food allergies simultaneously.